Amoxclav safe in lactation
Reading File
Finding Sources
Finding Sources
Searching PubMed
amoxicillin clavulanate breastfeeding lactation safety
Reading File
Finding Sources
Searching the Web
amoxicillin clavulanate safety breastfeeding lactation LactMed 2025
Here is a complete, evidence-based summary:
Amoxicillin-Clavulanate (Amoxclav) in Lactation
Bottom Line
Compatible with breastfeeding. Amoxclav is acceptable for use in nursing mothers. The American Academy of Pediatrics (AAP) classifies amoxicillin as "Maternal Medication Usually Compatible with Breastfeeding," and the NIH LactMed database (last updated December 2025) confirms amoxicillin-clavulanic acid is acceptable during nursing. It carries a Lactation Risk Category: L1 (safest).
Drug Levels in Breast Milk
- After a single 1 g oral amoxicillin dose, peak milk levels occur at 4-5 hours, averaging 0.69-0.81 mg/L.
- With a maternal dose of amoxicillin-clavulanate 500 mg three times daily, an exclusively breastfed infant receives a maximum of about 0.1 mg/kg/day of amoxicillin - roughly 0.25 to 0.5% of a typical infant therapeutic dose.
- The mean relative infant dose (RID) for amoxicillin is only 0.055% (maximum 0.328% even in worst-case modeling). An RID below 10% is generally considered safe.
- Data on clavulanate levels specifically in breast milk are limited, but the low oral bioavailability and small amounts transferred make infant exposure negligible.
Effects in Breastfed Infants
Adverse reactions are uncommon. The main risks are:
| Effect | Notes |
|---|---|
| Diarrhea | Most common; reported in ~3/25 infants in one follow-up study |
| Rash | Occasionally reported; usually mild |
| Thrush / candidiasis | Due to gut flora disruption; monitor for diaper rash or white oral plaques |
| Sensitization | Theoretical risk of future penicillin allergy; not well quantified |
| Restlessness | Rarely reported |
No serious adverse effects warranting medical attention have been documented in breastfed infants. No impact on maternal milk supply has been reported.
Special Considerations
- Timing of dose: If the mother is concerned, she can time the dose immediately after a feeding to minimise infant exposure (though this is generally not required given the low RID).
- Necrotizing enterocolitis (NEC): Amoxicillin-clavulanate use during pregnancy (not lactation) has been associated with increased NEC risk in neonates if used around the time of preterm delivery. This concern does not apply to breastfeeding use.
- Penicillin allergy: Contraindicated only if the infant is known to have a penicillin allergy.
- LactMed also lists Amoxclav as a preferred alternative antibiotic when clindamycin needs to be avoided during breastfeeding (systemic infections).
Authoritative Classifications
| Authority | Classification |
|---|---|
| AAP | Compatible with breastfeeding |
| Hale's Lactation Risk Category | L1 (Safest) |
| LactMed (NIH), updated Dec 2025 | Acceptable |
| Fishman's Pulmonary Diseases textbook | "Non-harmful effects been reported; AAP compatible" |
| WHO | Compatible |
Practical Recommendation
Amoxclav can be prescribed to a breastfeeding mother without interrupting nursing. Monitor the infant for diarrhea, rash, or signs of thrush. No dose adjustment or pumping-and-discarding is needed.
Sources: NIH LactMed - Amoxicillin-Clavulanic Acid (Dec 2025); NIH LactMed - Amoxicillin (Jun 2026); Fishman's Pulmonary Diseases, Table 96-3; StatPearls - Amoxicillin Clavulanate.
This is a shared conversation. Sign in to Orris to start your own chat.